BioCentury
ARTICLE | Company News

CSL sales and marketing update

December 22, 2014 8:00 AM UTC

CSL said CMS extended to September 2015 a new technology add-on payment (NTAP) for Kcentra for the urgent reversal of anticoagulation with vitamin K antagonist therapy, including warfarin, in adults ...